Penumbra (PEN) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

HOLX's New Offerings Likely to Revive Stock Amid Macro Woes
Zacks Feb 13 10:05 ET
Spotting Winners: Penumbra (NYSE:PEN) And Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks In Q3
Yahoo FinanceFeb 13 04:02 ET
Earnings Preview: Penumbra to Report Financial Results Post-market on February 18
Moomoo NewsFeb 12 20:00 ET
Home Healthcare Inflation Is Stubbornly High -- WSJ
WSJFeb 12 12:30 ET
Some Investors May Be Worried About Penumbra's (NYSE:PEN) Returns On Capital
Simply Wall StJan 30 13:49 ET
Imperative Care Secures FDA 510(k) Clearance for the Zoom System, Including the First Large-Bore .088" Catheter for Aspiration When Used With the Zoom Catheters, for Stroke Treatment
BusinesswireJan 27 08:00 ET

Comments

Moomoo AI

Feb 22, 2024 11:42

Despite the high P/S ratio, shareholders are holding onto Penumbra's stocks due to its strong future revenue prospects. The strong revenue forecasts are expected to keep the share price buoyant unless the analysts have significantly misjudged the company's potential.

Penumbra, Inc.'s (NYSE:PEN) Earnings Haven't Escaped The Attention Of Investors

Chatterbox Moo

Nov 21, 2023 04:20

Columns Medical-device Stock Selloff Caused by Ozempic Fears Has Gone Too Far—Now They're Rebounding

A new generation of highly effective weight-loss and diabetes drugs known as GLP-1s has led Wall Street to spell doom for companies that have profited from obesity problem. However, the reaction on Wall Street has been extreme, creating opportunities for cooler heads, some analysts and investors say.
To be sure, drugs such as $Novo-Nordisk A/S (NVO.US)$'s Ozempic and Wegovy, and Eli Lilly's Mounjaro have p...

11

Moomoo AI

Nov 9, 2023 05:00

Penumbra's earnings outlook could be brighter than reflected in the statutory profit due to one-off items. The company's profitability this year shows a good sign after previous losses.

The Strong Earnings Posted By Penumbra (NYSE:PEN) Are A Good Indication Of The Strength Of The Business

Moomoo AI

Nov 3, 2023 12:00

Penumbra's low ROE and declining net income over five years hint at sub-par performance. The earnings' decline, despite profit retention, could imply a struggling business or high payout ratio. Analyst estimates, however, foresee a better earnings growth rate.